A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus

被引:28
作者
Gao, GP
Engdahl, RK
Wilson, JM
机构
[1] Wistar Inst, Philadelphia, PA 19104 USA
[2] Univ Penn, Inst Human Gene Therapy, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Mol & Cellular Engn, Philadelphia, PA 19104 USA
关键词
D O I
10.1089/10430340050016283
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Production of E1-deleted adenovirus vectors for gene therapy has been plagued by the emergence of replication-competent adenovirus. A number of investigators have minimized homologous sequences between the vector and transfected E1 DNA in an attempt to avoid replication-competent adenovirus, We describe a HeLa-based cell line called GH329 that stably expresses the E1 locus from a promoter derived from the phosphoglycerate kinase gene. Overlap sequences with a standard E1-deleted vector that retains a full pIX transcriptional unit have been eliminated at the 5' end and minimized at the 3' end. The GH329 cell line plaques and produces E1-deleted adenovirus as well as 293 cells. Replication-competent virus has emerged after 5 passages of vector on 293 cells but was not detected after 20 passages on GH329 cells.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 18 条
[1]   CLONING AND EXPRESSION OF THE MOUSE PGK-1 GENE AND THE NUCLEOTIDE-SEQUENCE OF ITS PROMOTER [J].
ADRA, CN ;
BOER, PH ;
MCBURNEY, MW .
GENE, 1987, 60 (01) :65-74
[2]   ADENOVIRUS TYPE-5 VIRIONS CAN BE ASSEMBLED INVIVO IN THE ABSENCE OF DETECTABLE POLYPEPTIDE-IX [J].
COLBY, WW ;
SHENK, T .
JOURNAL OF VIROLOGY, 1981, 39 (03) :977-980
[3]   CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION [J].
DAI, YF ;
SCHWARZ, EM ;
GU, DL ;
ZHANG, WW ;
SARVETNICK, N ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1401-1405
[4]   New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses [J].
Fallaux, FJ ;
Bout, A ;
Van der Velde, I ;
Van den Wollenberg, DJM ;
Hehir, KM ;
Keegan, J ;
Auger, C ;
Cramer, SJ ;
Van Ormondt, H ;
Van der Eb, AJ ;
Valerio, D ;
Hoeben, RC .
HUMAN GENE THERAPY, 1998, 9 (13) :1909-1917
[5]   Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy [J].
Gao, GP ;
Yang, YP ;
Wilson, JM .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8934-8943
[6]  
GHOSHCHOUDHURY G, 1987, EMBO J, V8, P2077
[7]   TRANSIENT EXPRESSION OF GENES TRANSFERRED IN-VIVO INTO HEART USING FIRST-GENERATION ADENOVIRAL VECTORS - ROLE OF THE IMMUNE-RESPONSE [J].
GILGENKRANTZ, H ;
DUBOC, D ;
JUILLARD, V ;
COUTON, D ;
PAVIRANI, A ;
GUILLET, JG ;
BRIAND, P ;
KAHN, A .
HUMAN GENE THERAPY, 1995, 6 (10) :1265-1274
[8]   A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours [J].
Habib, NA ;
Hodgson, HJF ;
Lemoine, N ;
Pignatelli, M .
HUMAN GENE THERAPY, 1999, 10 (12) :2019-2034
[9]   Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence [J].
Hehir, KM ;
Armentano, D ;
Cardoza, LM ;
Choquette, TL ;
Berthelette, PB ;
Whitte, GA ;
Couture, LA ;
Everton, MB ;
Keegan, J ;
Martin, JM ;
Pratt, DA ;
Smith, MP ;
Smith, AE ;
Wadsworth, SC .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8459-8467
[10]  
Imler JL, 1996, GENE THER, V3, P75